Cynthia investigates the application of adult human bone marrow derived mesenchymal stem cells to treat osteoarthritis. The aim of her ongoing research is to assess the combination of mesenchymal stem cells (MSCs) and growth/differentiation factor 5 (GDF-5) as a potential therapeutic for arthritis, specifically focusing on the deposition of extracellular matrix proteins.